.017 line taken out in one hit, 8m shares.Doubt we will see much movement today, but it's a good sign that someone's willing to take the punt at that level.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%